When you come to a patient, right, when you're not testing, you're not actually doing something to say, okay, let's, let's have a study here
It may improve regulatory posture but does not automatically authorize compounding
This product should only be handled by licensed and qualified professionals
Outside the current work, JS has received honoraria for talks and/or consultancy and/or research funding from Apitope, AstraZeneca, Bayer, Berlin Chemie, Boehringer Ingelheim, Bristol-Meyers Squibb, Eli Lilly, GI Dynamics, GlaxoSmithKline, Intarcia, Ipsen, Janssen, LifeScan, MedScape, MSD, Novartis, Novo Nordisk, OmniaMed, Pfizer, Roche, Sanofi, Servier, Takeda and Ypsomed
investigators should attend to the regulatory context, since none of the three components are approved as drugs in any major jurisdiction